Erik Laughner

9.6k citations

14 papers · 8.1k indexed · 5 hit papers · h-index 14

Impact in

Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 1%
- Angiogenesis and VEGF in Cancer
- Mitochondrial Function and Pathology
- RNA modifications and cancer
- Metabolism, Diabetes, and Cancer

Papers in

Cancer Research 12
- Cancer, Hypoxia, and Metabolism 12
- Cancer-related molecular mechanisms research 3
Physiology 5
- Adipose Tissue and Metabolism 5

Co-authors: Gregg L. Semenza Jonathan W. Simons Kelly A. Chiles Lori E. Kotch Narayan V. Iyer David Zagzag Faton Agani Aimee Y. Yu
Journals: Cancer (2 papers)Genes & Development (1 paper)Human Molecular Genetics (1 paper)Journal of Biological Chemistry (1 paper)Novartis Foundation symposium (1 paper)
Partner nations: United States Switzerland

In The Last Decade

Erik Laughner

14 papers receiving 8.0k citations

Hit Papers

5 papers align trajectories log scale

HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression 2001 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 Molecular and Cellular Biology
2000 PubMed
2000 Cancer
1999 PubMed
1998 Genes & Development

Peers

Countries citing papers authored by Erik Laughner

Since Specialization

Citations

This map shows the geographic impact of Erik Laughner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Laughner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Laughner more than expected).

Fields of papers citing papers by Erik Laughner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Laughner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Laughner. The network helps show where Erik Laughner may publish in the future.

Co-authors

The 25 scholars most cited alongside Erik Laughner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Laughner Line = papers co-authored together Erik Laughner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Hypoxia, HIF-1, and the Pathophysiologi of Common Human Diseases Kluwer Academic Publishers eBooks ·Gregg L. Semenza, Faton Agani, David M. Feldser, Roman Oros, Lori E. Kotch, Erik Laughner, Aimee Y. Yu	2006	159
2	Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses Journal of Immunological Methods ·Hideki Ueno, Irina Y. Tcherepanova, Rafaella Camargo Mendonça de Mello, Erik Laughner, Bayu Andhika, Karolina Palucka, Jacques Banchereau	2004	18
3	HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression Molecular and Cellular Biology ·Erik Laughner, Panthea Taghavi, Kelly A. Chiles, Patrick C. Mahon, Gregg L. Semenza Hit paper breakdown →	2001	1037
4	‘The Metabolism of Tumours’: 70 Years Later Novartis Foundation symposium ·Gregg L. Semenza, Dmitri Artemov, Atul Bedi, Zaver M. Bhujwalla, Kelly A. Chiles, David M. Feldser, Erik Laughner, Rajani Ravi, Jonathan W. Simons, Panthea Taghavi, Hua Zhong	2001	167
5	Expression of hypoxia-inducible factor 1? in brain tumors Cancer ·David Zagzag, Hua Zhong, Joanne M. Scalzitti, Erik Laughner, Jonathan W. Simons, Gregg L. Semenza Hit paper breakdown →	2000	515
6	Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations Proceedings of the National Academy of Sciences ·Thomas R. Sutter, Erik Laughner, Gregg L. Semenza	2000	243
7	Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. PubMed ·Hua Zhong, Kelly A. Chiles, David M. Feldser, Erik Laughner, Colleen F. Hanrahan, Manuel Costales Sáez, Jonathan W. Simons, Gregg L. Semenza Hit paper breakdown →	2000	1238
8	Expression of hypoxia‐inducible factor 1α in brain tumors Cancer ·David Zagzag, Hua Zhong, Joanne M. Scalzitti, Erik Laughner, Jonathan W. Simons, Gregg L. Semenza	2000	40
9	Defective Vascularization of HIF-1α-Null Embryos Is Not Associated with VEGF Deficiency but with Mesenchymal Cell Death Developmental Biology ·Lori E. Kotch, Narayan V. Iyer, Erik Laughner, Gregg L. Semenza	1999	338
10	Regulation of Cardiovascular Development and Physiology by Hypoxia‐Inducible Factor 1^a Annals of the New York Academy of Sciences ·Gregg L. Semenza, Faton Agani, Narayan V. Iyer, Lori E. Kotch, Erik Laughner, Красюкова Вероника Олеговна, Aimee Y. Yu	1999	93
11	Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. PubMed ·Hua Zhong, Angelo M. De Marzo, Erik Laughner, Michael Lim, David A. Hilton, David Zagzag, Peter Buechler, William B. Isaacs, Gregg L. Semenza, Jonathan W. Simons Hit paper breakdown →	1999	1913
12	Cellular and developmental control of O₂ homeostasis by hypoxia-inducible factor 1α Genes & Development ·Narayan V. Iyer, Lori E. Kotch, Faton Agani, Sandra W. Leung, Erik Laughner, Roland H. Wenger, Max Gassmann, John D. Gearhart, Ann M. Lawler, Aimee Y. Yu, Gregg L. Semenza Hit paper breakdown →	1998	2089
13	Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer Journal of Biological Chemistry ·Yuxiang Liu, Helen Christou, Toshisuke Morita, Erik Laughner, Gregg L. Semenza, Stella Kourembanas	1998	202
14	Perinatal Lethality and Multiple Craniofacial Malformations in MSX2 Transgenic Mice Human Molecular Genetics ·Jonathan M. Winograd, Muredach P. Reilly, M. Alder, Janita Lutz, Erik Laughner, Xiaoqiang Xu, Alireza Ildoromi, Toshio Asakura, Craig Vander Kolk, John D. Strandberg, Gregg L. Semenza	1997	91

About Erik Laughner

Erik Laughner is a scholar working on Cancer Research, Physiology, Genetics, Biochemistry and Genetics, having authored 14 papers that have together received 8.1k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (12 papers), Adipose Tissue and Metabolism (5 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers), High Altitude and Hypoxia (2 papers), Fibroblast Growth Factor Research (1 paper), Mesenchymal stem cell research (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Cancer Research (5.7k citations), Molecular Biology (5.0k citations), Biochemistry (350 citations), Oncology (1.2k citations) and Genetics (1.1k citations). Erik Laughner has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Gregg L. Semenza, Jonathan W. Simons, Kelly A. Chiles, Lori E. Kotch, Narayan V. Iyer, David Zagzag, Faton Agani, Aimee Y. Yu, Panthea Taghavi and Patrick C. Mahon. Their work appears in journals such as Cancer, Genes & Development, Human Molecular Genetics, Journal of Biological Chemistry and Novartis Foundation symposium.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact